BSE Live
Jan 02, 14:41Prev. Close
1720.40
Open Price
1722.00
Bid Price (Qty.)
1724.35 (17)
Offer Price (Qty.)
1725.00 (1)
NSE Live
Jan 02, 14:41Prev. Close
1721.10
Open Price
1721.10
Bid Price (Qty.)
1725.00 (692)
Offer Price (Qty.)
1725.10 (96)
| Profit & Loss account of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| INCOME | |||
| Revenue From Operations [Gross] | 1,056.01 | 897.59 | |
| Less: Excise/Sevice Tax/Other Levies | 48.73 | 53.53 | |
| Revenue From Operations [Net] | 1,007.28 | 844.06 | |
| Total Operating Revenues | 1,007.28 | 844.06 | |
| Other Income | 232.87 | 115.29 | |
| Total Revenue | 1,240.15 | 959.35 | |
| EXPENSES | |||
| Cost Of Materials Consumed | 248.73 | 230.80 | |
| Purchase Of Stock-In Trade | 329.50 | 184.93 | |
| Operating And Direct Expenses | 24.97 | 19.61 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.45 | -16.89 | |
| Employee Benefit Expenses | 82.78 | 68.55 | |
| Finance Costs | 0.00 | 0.00 | |
| Depreciation And Amortisation Expenses | 32.83 | 23.55 | |
| Other Expenses | 200.82 | 155.09 | |
| Total Expenses | 922.53 | 665.64 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 317.62 | 293.71 | |
| Exceptional Items | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 317.62 | 293.71 | |
| Tax Expenses-Continued Operations | |||
| Current Tax | 6.53 | 8.53 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | |
| Deferred Tax | 11.24 | 26.12 | |
| Tax For Earlier Years | 0.00 | 0.00 | |
| Total Tax Expenses | 17.77 | 34.65 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 299.85 | 259.06 | |
| Profit/Loss From Continuing Operations | 312.30 | 246.41 | |
| Profit/Loss For The Period | 312.30 | 246.41 | |
| OTHER ADDITIONAL INFORMATION | |||
| EARNINGS PER SHARE | |||
| Basic EPS (Rs.) | 16.83 | 26.56 | |
| Diluted EPS (Rs.) | 16.83 | 26.56 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | |||
| Imported Raw Materials | 72.65 | 69.76 | |
| Indigenous Raw Materials | 153.79 | 142.57 | |
| STORES, SPARES AND LOOSE TOOLS | |||
| Imported Stores And Spares | 0.09 | 0.05 | |
| Indigenous Stores And Spares | 8.41 | 4.55 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | |||
| Equity Share Dividend | 69.57 | 60.29 | |
| Tax On Dividend | 9.91 | 7.88 | |
| Equity Dividend Rate (%) | 75.00 | 65.00 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend